Latest Regulatory News

Page 56 of 803
ARC Funds Limited has been suspended from ASX trading due to a failure to maintain the minimum number of directors required by law, raising questions about its governance and future compliance.
Claire Turing
Claire Turing
13 Mar 2026
iCandy Interactive is exploring a US listing for its subsidiary Lemon Sky Studios to unlock shareholder value, while facing a likely ASX delisting due to audit delays. The company also plans a capital raise to support these initiatives.
Sophie Babbage
Sophie Babbage
13 Mar 2026
Pacific Lime and Cement Limited has formalised a landmark agreement with the Papua New Guinea government to develop the country’s first integrated lime and cement manufacturing platform, marking a major step in PNG’s industrial growth.
Maxwell Dee
Maxwell Dee
13 Mar 2026
The Brazilian government has imposed a 12% tax on crude oil exports effective immediately, a move framed as windfall profit sharing amid high oil prices. Karoon Energy, with significant Brazilian operations, faces new cost pressures as the tax awaits potential ratification by Congress.
Maxwell Dee
Maxwell Dee
13 Mar 2026
EVE Health Group has raised $0.9 million to advance its pharmaceutical reformulation programs targeting global markets worth over US$30 billion. The funding will support development of improved delivery technologies for medicines nearing patent expiry.
Ada Torres
Ada Torres
13 Mar 2026
Australian Strategic Materials and Energy Fuels have amended their acquisition deal, replacing a special dividend with a direct cash payment to ASM shareholders, while maintaining the original share swap terms.
Maxwell Dee
Maxwell Dee
13 Mar 2026
H3 Energy has appointed LAB Energy Advisors to spearhead farm-in talks for its Alinya project, a vast and underexplored oil and gas prospect in South Australia’s Officer Basin. The move aims to accelerate partner engagement ahead of drilling a potentially game-changing well.
Maxwell Dee
Maxwell Dee
13 Mar 2026
Immutep Limited’s shares have resumed trading following the release of an interim futility analysis from its pivotal TACTI-004 Phase III trial of eftilagimod alfa.
Ada Torres
Ada Torres
13 Mar 2026
Immutep Limited has discontinued its pivotal TACTI-004 Phase III trial in first-line non-small cell lung cancer following an independent futility analysis, prompting a strategic reassessment of its clinical program and finances.
Ada Torres
Ada Torres
13 Mar 2026
Felix Gold’s 2025 drilling program at Treasure Creek in Alaska has revealed further high-grade antimony and gold mineralisation, extending the NW Array system west and south and reinforcing its potential as a strategic US antimony source.
Maxwell Dee
Maxwell Dee
13 Mar 2026
Westgold Resources has completed the demerger of its non-core Reedy and Comet Projects to newly formed Valiant Gold, which has attracted $75 million in oversubscribed IPO applications ahead of its ASX debut.
Maxwell Dee
Maxwell Dee
13 Mar 2026
Terrain Minerals has launched a targeted air-core drilling campaign at its Lort River Project in Western Australia, aiming to expand on previously identified high-grade rare earth element mineralisation within a large regolith clay basin.
Maxwell Dee
Maxwell Dee
13 Mar 2026